Ozempic Shots Cost Guide: Pricing, Coverage & Compounded Options

Last reviewed: May 18, 2026

Last updated: May 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Ozempic injection costs typically range from $900 to $1,400 per month without insurance, depending on dose strength and pharmacy. Brand-name GLP-1 receptor agonists represent significant out-of-pocket expenses for many patients, making cost comparison and alternative evaluation critical before starting treatment.

Understanding medication costs is only part of informed decision-making. Genetic predispositions in GLP-1 receptor and metabolic pathways may provide context for how an individual responds to peptide therapies. PlexusDx offers both cost-effective compounded options and genetic insights to support a more personalized conversation with your healthcare provider.

Understanding Ozempic Injection Pricing and Factors

Ozempic (semaglutide) injection pricing depends on multiple variables: dose strength (0.25 mg, 0.5 mg, 1 mg), prescription volume, insurance formulary status, and pharmacy. Cash prices at major chains frequently exceed $1,200 monthly for higher doses without manufacturer discounts.

Insurance coverage varies significantly. Some plans cover Ozempic for diabetes with prior authorization; others require documented weight-loss indication or failed oral medications first. Copays range from $100 to $500+ depending on tier placement and deductible status.

GLP-1 Medication Cost Comparison: Brand Versus Compounded

Branded GLP-1 medications carry premium pricing due to patent exclusivity and manufacturing overhead. Compounded alternatives offer similar active pharmaceutical ingredients at substantially lower cost through licensed 503A pharmacies. Comparing total cost-of-ownership—injection supplies, storage, frequency—helps identify the most economical option aligned with your clinical needs.

PlexusDx compounded offerings provide transparent, tiered pricing without hidden surcharges. Monthly costs reflect actual pharmacy compounding expenses, not marketing or brand licensing.

Medication Option	Approximate Monthly Cost	Formulation	Typical Duration
Ozempic (branded semaglutide)	$900–$1,400	Injectable pen	4 weeks (1 injection)
PlexusDx Compounded Semaglutide	$149	Injectable vial	Variable per protocol
Mounjaro (branded tirzepatide)	$1,000–$1,500	Injectable pen	4 weeks (1 injection)
PlexusDx Compounded Tirzepatide	$249	Injectable vial	Variable per protocol

Insurance Coverage, Copay Assistance, and Out-of-Pocket Strategies

Most insurance plans classify GLP-1 medications as specialty drugs, requiring prior authorization and documentation of medical necessity. Medicare coverage for semaglutide exists for diabetes only; weight-loss indication requires private insurance or cash pay. Manufacturer copay programs can reduce out-of-pocket costs to $0–$250 monthly if eligible.

If brand-name coverage remains cost-prohibitive, discussing compounded alternatives with your prescriber may align medical efficacy with budget constraints. Compounded medications bypass brand-negotiated insurance tiers and often qualify for transparent cash pricing available immediately.

Genetic Predispositions and How They Relate to GLP-1 Treatment Selection

Genetic variants in the GLP-1 receptor (GLP1R rs6923761), GIPR pathway (rs1800437), and metabolic regulators (FTO rs9939609, MC4R rs17782313) may influence how individuals respond to peptide-based therapies. These predispositions do not predict exact medication response but may provide context for provider discussions about treatment likelihood and adjustment needs.

PlexusDx Precision Peptide Genetic Test reveals predispositions in these peptide-pathway variants for $99 as an add-on or $298 standalone. This information should be interpreted with your qualified healthcare provider to inform whether semaglutide, tirzepatide, or alternative GLP-1 approaches align with your genetic profile and clinical goals.

How PlexusDx Supports a More Personalized Approach

PlexusDx compounded GLP-1 medications provide medical-grade injectable or oral formulations at 60–75% lower cost than branded alternatives, removing financial barriers that often delay treatment initiation. Compounding through licensed 503A pharmacies ensures consistent quality, sterility, and potency without the premium pricing embedded in brand-name products.

The Precision Peptide Genetic Test may help provide context regarding predispositions in GLP-1 receptor sensitivity, GIPR signaling, and metabolic regulation pathways. This information does not guarantee treatment response but can support a more informed conversation with your provider about whether GLP-1 therapy is clinically appropriate and which formulation or dose approach aligns with your genetic profile.

Understanding your genetic predispositions alongside medication cost, insurance coverage, and clinical efficacy evidence enables a more comprehensive decision-making framework. PlexusDx supports this integrated approach by combining affordability, genetic insights, and provider collaboration to help patients access personalized GLP-1 treatment aligned with both their biology and budget.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.